Fabio
66 lines
2.8 KiB
Markdown
66 lines
2.8 KiB
Markdown
---
|
|
type: "Bill"
|
|
title: "Prescription Drug Affordability Board - Upper Payment Limits"
|
|
description: "Prescription Drug Affordability Board - Upper Payment Limits"
|
|
jurisdiction: "us/states/md"
|
|
legislature: "Maryland General Assembly"
|
|
session: "2023"
|
|
identifier: "SB 202"
|
|
citation: "Maryland SB 202 (2023)"
|
|
classification: ["bill"]
|
|
subjects: []
|
|
status: "enacted"
|
|
primary_sponsors: ["Feldman"]
|
|
version_count: 3
|
|
action_count: 13
|
|
vote_count: 0
|
|
first_action: "2023-01-20"
|
|
last_action: "2023-04-11"
|
|
source: "openstates"
|
|
source_identifier: "ocd-bill/4c5cd590-786d-49fb-9eab-ad6d2cbcfc27"
|
|
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0202?ys=2023RS&search=True"
|
|
source_hash: "730cd951c7a24e01f054e2c3cde46855290ef08f2c1f1e105b74c48e005b41a2"
|
|
vintage: "2026-07-01"
|
|
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
|
retrieved_at: "2026-07-06"
|
|
confidence: "reported"
|
|
tags: ["legislation", "bill", "us-md"]
|
|
---
|
|
|
|
# Maryland SB 202 (2023) — Prescription Drug Affordability Board - Upper Payment Limits
|
|
|
|
## Version chain
|
|
|
|
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
|
|
|
1. **Chapter - Prescription Drug Affordability Board - Upper Payment Limits** (committee substitute) — [source](http://mgaleg.maryland.gov/2023RS/Chapters_noln/CH_40_sb0202t.pdf)
|
|
2. **First - Prescription Drug Affordability Board - Upper Payment Limits** (committee substitute) — [source](http://mgaleg.maryland.gov/2023RS/bills/sb/sb0202f.pdf)
|
|
3. **Third - Prescription Drug Affordability Board - Upper Payment Limits** (committee substitute) — [source](http://mgaleg.maryland.gov/2023RS/bills/sb/sb0202t.pdf)
|
|
|
|
## Sponsors
|
|
|
|
- Feldman — primary (person)
|
|
|
|
## Timeline
|
|
|
|
The legislative action history — every referral, reading, and vote.
|
|
|
|
- **2023-01-20** First Reading Finance `referral-committee`
|
|
- **2023-01-21** Hearing 2/08 at 1:00 p.m.
|
|
- **2023-02-13** Favorable Report by Finance `committee-passage-favorable`
|
|
- **2023-02-14** Favorable Adopted `committee-passage-favorable`
|
|
- **2023-02-14** Second Reading Passed
|
|
- **2023-02-16** Third Reading Passed `passage`
|
|
- **2023-02-20** Referred Health and Government Operations `referral-committee`
|
|
- **2023-03-14** Hearing 3/23 at 1:00 p.m.
|
|
- **2023-03-27** Favorable Report by Health and Government Operations `committee-passage-favorable`
|
|
- **2023-03-28** Favorable Adopted Second Reading Passed `committee-passage-favorable`
|
|
- **2023-03-29** Third Reading Passed `passage`
|
|
- **2023-03-30** Returned Passed
|
|
- **2023-04-11** Approved by the Governor - Chapter 40 `executive-signature`
|
|
|
|
## Source
|
|
|
|
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/4c5cd590-786d-49fb-9eab-ad6d2cbcfc27`. Confidence: reported (aggregated from official Maryland legislature records).
|
|
|